Evaluation and Initial Treatment of Persistent Proteinuria
Start with an ACE inhibitor or ARB uptitrated to the maximally tolerated dose as first-line therapy for persistent proteinuria, combined with aggressive lifestyle modifications including sodium restriction to <2.0 g/day, while targeting a systolic blood pressure <120 mmHg. 1
Initial Evaluation
Quantification and Confirmation
- Use a spot urine protein-to-creatinine ratio (PCR) rather than 24-hour collections for practical assessment 2, 3
- Normal PCR is <0.3 mg/mg (or <300 mg/g) in children ≥2 years and adults
- Confirm persistence by repeating the test: proteinuria must be present in 2 of 3 samples to establish true persistent proteinuria 2
- Exclude orthostatic proteinuria by obtaining a first morning void specimen (PCR should be <0.3) 3, 4
- Rule out transient causes: fever, vigorous exercise (avoid 24 hours before testing), stress, or cold exposure 4
Diagnostic Workup
Obtain baseline laboratory assessment:
- Serum creatinine and eGFR
- Serum albumin (to identify nephrotic syndrome if <3.0 g/dL with edema)
- Electrolytes including potassium and bicarbonate
- Lipid panel
- Hemoglobin A1c (screen for diabetes)
- Complement levels (C3, C4) if glomerulonephritis suspected
- Renal ultrasound to assess kidney size and detect structural abnormalities 5
Critical caveat: Review all medications for nephrotoxic agents (NSAIDs, lithium, calcineurin inhibitors) that may cause tubular proteinuria 5
Initial Treatment Algorithm
First-Line Pharmacotherapy
ACE inhibitor or ARB monotherapy is the cornerstone 1, 6:
- Uptitrate to maximally tolerated or allowed daily dose regardless of whether hypertension is present 1
- Continue therapy even with modest, stable serum creatinine increases up to 30% 1
- Do NOT combine ACE inhibitors with ARBs - this increases adverse events (hyperkalemia, acute kidney injury) without proven benefit 6
Important exception: Delay ACE/ARB initiation in patients with abrupt-onset nephrotic syndrome, particularly minimal change disease, as these drugs can precipitate acute kidney injury 1
Blood Pressure Targets
- Target systolic BP <120 mmHg using standardized office measurement 1
- In practice, achieving 120-130 mmHg is acceptable in most patients with glomerular disease 1
Proteinuria Goals
- General target: <0.5-1.0 g/day 1
- Recent evidence suggests even low-grade proteinuria (0.5-1.0 g/day) increases risk of progression, so aim for <0.5 g/day when achievable 7, 8
- Reassess at 6 months: achieving proteinuria <0.80 g/g is associated with better long-term outcomes 8
Mandatory Lifestyle Modifications
These are synergistic with pharmacotherapy and non-negotiable 1:
- Dietary sodium restriction to <2.0 g/day (<90 mmol/day) - this is critical
- Weight normalization if overweight/obese
- Smoking cessation
- Regular exercise
- In adolescents, screen for recreational drug use and anabolic steroid use 9
Monitoring and Management
Laboratory Surveillance
- Monitor electrolytes and creatinine frequently after initiating ACE/ARB 1
- Check potassium within 1-2 weeks of starting therapy
- Recheck proteinuria at 6 months to assess response 8
Managing Hyperkalemia
To continue beneficial ACE/ARB therapy 1:
- Use potassium-wasting diuretics (thiazides or loops)
- Consider potassium-binding agents
- Treat metabolic acidosis if bicarbonate <22 mmol/L (acidosis worsens hyperkalemia)
Patient Education
Counsel patients to hold ACE/ARB and diuretics during:
- Acute illnesses causing volume depletion
- Gastroenteritis with vomiting/diarrhea
- "Sick days" with reduced oral intake 1
Refractory Cases
If proteinuria persists despite maximal medical therapy 1:
- Intensify sodium restriction further
- Consider adding mineralocorticoid receptor antagonists (spironolactone/eplerenone) - monitor closely for hyperkalemia
- Refer to nephrology for consideration of kidney biopsy and disease-specific immunosuppression
When to Refer to Nephrology
Immediate referral indicated for 3, 4:
- Persistent proteinuria >6 months despite treatment
- Proteinuria with active urinary sediment or hematuria
- Hypertension refractory to treatment
- Declining eGFR or renal insufficiency
- Hypocomplementemia suggesting glomerulonephritis
- Signs/symptoms of vasculitic disease
- Nephrotic-range proteinuria (>3.0-3.5 g/day)